Details of the Drug Formulaction

General Information of Drug Formulation (ID: F22463)

• Formulation Name: Vorapaxar 2.08 mg tablet
• Company: Aralez Pharmaceuticals; Merck Sharp & Dohme

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Vorapaxar	(DMA16BR)	Myocardial infarction	BA41-BA43	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Carmellose sodium	(E00625)	Not Available	Disintegrant
Ferric hydroxide oxide yellow	(E00539)	23320441	Colorant
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Triacetin	(E00080)	5541	Humectant; Plasticizing agent; Solvent